Publications by authors named "Kota Takuma"
Diabetes Obes Metab
August 2023
Article Synopsis
- The study aimed to compare how baseline characteristics of patients treated with dapagliflozin and sitagliptin affected glycaemic control outcomes, specifically measuring time in range (TIR) and other metrics like HbA1c levels.
- It involved 340 Japanese patients with early-stage type 2 diabetes, analyzing the rates of achieving specific glycemic targets based on their body mass index (BMI).
- Results showed that sitagliptin performed better for patients with a lower BMI, while dapagliflozin was more effective for those with a higher BMI in maintaining desired glycaemic control.
